(Q34586781)

English

Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals (English)

1 reference

Europe PubMed Central

3 August 2017

author name string

Weiting Du

1

1 reference

Europe PubMed Central

3 August 2017

Yueh-Wei Shen

2

1 reference

Europe PubMed Central

3 August 2017

Wen-Hui Lee

3

1 reference

Europe PubMed Central

3 August 2017

Ding Wang

4

1 reference

Europe PubMed Central

3 August 2017

Sachiko Paz

5

1 reference

Europe PubMed Central

3 August 2017

Fouad Kandeel

6

1 reference

Europe PubMed Central

3 August 2017

Chih-Pin Liu

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

11 February 2013

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

e56209

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

11 February 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Helios expression is a marker of T cell activation and proliferation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Autoimmunity and the pathogenesis of type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Checkpoints in lymphocyte development and autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Expansion of human regulatory T-cells from patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Role of regulatory T cells for the treatment of type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Update in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Multiple immuno-regulatory defects in type-1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3569420

7 July 2018

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056209

21 January 2018

Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056209

21 January 2018

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056209

21 January 2018

Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056209

21 January 2018

Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0056209

21 January 2018

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+CD25high regulatory T cells in human autoimmune diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://pubmed.ncbi.nlm.nih.gov/23409157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0056209

1 reference

Europe PubMed Central

3 August 2017

2013PLoSO...856209D

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34586781&oldid=1865640634"